• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用血液学参数为资源匮乏地区的艾滋病毒/艾滋病患者监测开发和验证三参数评分系统

Development and Validation of a Three-Parameter Scoring System for Monitoring HIV/AIDS Patients in Low-Resource Settings Using Hematological Parameters.

作者信息

Al-Mughales Jamil A

机构信息

Department of Clinical Microbiology and Immunology, King Abdul-Aziz University, Jeddah, Kingdom of Saudi Arabia.

Department of Clinical Laboratories-Diagnostic Immunology Division, King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia.

出版信息

HIV AIDS (Auckl). 2023 Oct 5;15:599-610. doi: 10.2147/HIV.S431139. eCollection 2023.

DOI:10.2147/HIV.S431139
PMID:37818243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10561757/
Abstract

OBJECTIVE

This study aimed to test the validity of a composite score using complete blood count (CBC) for monitoring HIV patients receiving antiretroviral therapy (ART) in the absence of viral load and CD4 count.

METHODS

This retrospective cohort study analyzed the laboratory data of 82 HIV patients who had pre- and post-treatment viral load, CD4 count, and CBC data. Pre- and post-treatment data were pooled to analyze the correlation of CBC parameters with Polymerase Chain Reaction (PCR) ranks and their performance in indicating a CD4 count<200 cells/mm3 using the Operating Characteristics Curve (ROC), with the determination of cutoffs. A score combining the significant parameters was tested to predict a CD4 count of <200.

RESULTS

Total lymphocyte count (TLC), percentage (TLP), and hemoglobin concentration (Hb) were the most significant parameters, showing negative correlations with PCR (Spearman's Rho = -0.357 to -0.242). The risk of acquired immunodeficiency syndrome (AIDS) was independently associated with TLC<1345 cells/mm3 (OR=2.92), TLP<29.07% (OR=3.53), and Hb<10.55 mg/dL (OR=3.60). A combined score of 2-3 indicated a CD4 count<200 with an odds ratio of 8.3-86.7.

CONCLUSION

The proposed 3-parameter score combining the use of TLC, TLP, and Hb, is an affordable and practical approach that may have clinical utility in monitoring HIV patients receiving ART in low-resource settings.

摘要

目的

本研究旨在检验在缺乏病毒载量和 CD4 细胞计数的情况下,使用全血细胞计数(CBC)综合评分监测接受抗逆转录病毒治疗(ART)的 HIV 患者的有效性。

方法

这项回顾性队列研究分析了 82 例 HIV 患者治疗前后的病毒载量、CD4 细胞计数和 CBC 数据。将治疗前和治疗后的数据分析合并,以分析 CBC 参数与聚合酶链反应(PCR)分级的相关性,以及它们在使用操作特征曲线(ROC)指示 CD4 细胞计数<200 个细胞/mm³ 时的表现,并确定临界值。对结合显著参数的评分进行测试,以预测 CD4 细胞计数<200。

结果

总淋巴细胞计数(TLC)、百分比(TLP)和血红蛋白浓度(Hb)是最显著的参数,与 PCR 呈负相关(Spearman 相关系数 = -0.357 至 -0.242)。获得性免疫缺陷综合征(AIDS)的风险与 TLC<1345 个细胞/mm³(OR = 2.92)、TLP<29.07%(OR = 3.53)和 Hb<10.55 mg/dL(OR = 3.60)独立相关。综合评分为 2 - 3 表明 CD4 细胞计数<200,比值比为 8.3 - 86.7。

结论

所提出的结合使用 TLC、TLP 和 Hb 的三参数评分是一种经济实用的方法,可能在资源匮乏地区监测接受 ART 的 HIV 患者方面具有临床应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/313a/10561757/34e37f841a6c/HIV-15-599-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/313a/10561757/ee1154137b8e/HIV-15-599-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/313a/10561757/34e37f841a6c/HIV-15-599-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/313a/10561757/ee1154137b8e/HIV-15-599-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/313a/10561757/34e37f841a6c/HIV-15-599-g0002.jpg

相似文献

1
Development and Validation of a Three-Parameter Scoring System for Monitoring HIV/AIDS Patients in Low-Resource Settings Using Hematological Parameters.利用血液学参数为资源匮乏地区的艾滋病毒/艾滋病患者监测开发和验证三参数评分系统
HIV AIDS (Auckl). 2023 Oct 5;15:599-610. doi: 10.2147/HIV.S431139. eCollection 2023.
2
Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.在内罗毕肯雅塔国家医院启动抗逆转录病毒治疗时,总淋巴细胞计数作为CD4 + T细胞计数的替代标志物。
East Afr Med J. 2007 Oct;84(10):466-72. doi: 10.4314/eamj.v84i10.9564.
3
Total lymphocyte count and hemoglobin combined to predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/AIDS.总淋巴细胞计数和血红蛋白相结合可预测HIV/AIDS患者CD4淋巴细胞计数低于200个细胞/立方毫米。
Acta Med Indones. 2008 Apr;40(2):59-62.
4
Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.总淋巴细胞计数作为替代标志物来识别需要抗逆转录病毒治疗的印度产前和产后妇女时的低敏感性。
J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):338-42. doi: 10.1097/QAI.0b013e318157684b.
5
Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.在资源有限的环境中,将总淋巴细胞计数和血红蛋白结合在一种算法中,以启动高效抗逆转录病毒疗法的使用。
AIDS. 2003 Jun 13;17(9):1311-7. doi: 10.1097/00002030-200306130-00005.
6
Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.HIV感染患者总淋巴细胞计数与CD4计数的相关性分析:一项回顾性评估
J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):712. doi: 10.1007/s11596-011-0588-8. Epub 2011 Oct 25.
7
Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries.在印度和其他资源有限的国家,淋巴细胞总数(TLC)是预防机会性感染时机选择的一项有用指标。
J Acquir Immune Defic Syndr. 2002 Dec 1;31(4):378-83. doi: 10.1097/00126334-200212010-00002.
8
Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的HIV-1感染女性中,总淋巴细胞计数、血红蛋白和迟发型超敏反应作为死亡和艾滋病疾病预测指标的研究
J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):383-92. doi: 10.1097/00126334-200404010-00008.
9
Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count.在资源有限的环境中,与CD4细胞计数相比,将总淋巴细胞计数和血红蛋白浓度联合作为启动高效抗逆转录病毒治疗的替代标志物。
West Indian Med J. 2014 Sep;63(5):460-4. doi: 10.7727/wimj.2013.132. Epub 2014 May 8.
10
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.在资源有限的环境中,总淋巴细胞计数可作为 CD4 计数的替代标志物。
BMC Infect Dis. 2012 Jun 7;12:128. doi: 10.1186/1471-2334-12-128.

引用本文的文献

1
Evolution of Hematobiochemical Profiles in Newly Diagnosed HIV Patients and HIV-TB Co-Infected Patients: Correlation with Immunological and Virological Status.新诊断的HIV患者和HIV-TB合并感染患者血液生化指标的演变:与免疫和病毒学状态的相关性
Immunotargets Ther. 2024 Dec 10;13:691-705. doi: 10.2147/ITT.S495295. eCollection 2024.

本文引用的文献

1
Anemia in HIV/AIDS Patients on Antiretroviral Treatment at Ayder Specialized Hospital, Mekele, Ethiopia: A Case-Control Study.埃塞俄比亚默克莱市阿伊德专科医院接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者的贫血情况:一项病例对照研究。
J Blood Med. 2020 Oct 21;11:379-387. doi: 10.2147/JBM.S275467. eCollection 2020.
2
Prevalence of Anemia and Its Associated Factors in Antiretroviral-Treated HIV/AIDS-Positive Adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia.2013年至2018年埃塞俄比亚德布雷伯汉转诊医院接受抗逆转录病毒治疗的HIV/AIDS阳性成年患者贫血患病率及其相关因素
Adv Hematol. 2020 Mar 11;2020:2513578. doi: 10.1155/2020/2513578. eCollection 2020.
3
Scale-up of Kenya's national HIV viral load program: Findings and lessons learned.
肯尼亚国家艾滋病毒病毒载量检测项目的扩大:研究结果与经验教训
PLoS One. 2018 Jan 11;13(1):e0190659. doi: 10.1371/journal.pone.0190659. eCollection 2018.
4
Body Mass Index, Haemoglobin, and Total Lymphocyte Count as a Surrogate for CD4 Count in Resource Limited Settings.在资源有限的环境中,体重指数、血红蛋白和总淋巴细胞计数作为CD4细胞计数的替代指标
J Biomark. 2017;2017:7907352. doi: 10.1155/2017/7907352. Epub 2017 Apr 18.
5
Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.扩大艾滋病毒病毒载量监测范围的进展情况-撒哈拉以南非洲七个国家,2015 年 1 月至 2016 年 6 月。
MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1332-1335. doi: 10.15585/mmwr.mm6547a2.
6
Current status of HIV/AIDS in the ART era.抗逆转录病毒治疗时代的艾滋病毒/艾滋病现状
J Infect Chemother. 2017 Jan;23(1):12-16. doi: 10.1016/j.jiac.2016.10.002. Epub 2016 Nov 5.
7
Effect of sociodemographic factors on survival of people living with HIV.社会人口学因素对艾滋病毒感染者生存情况的影响。
Curr Opin HIV AIDS. 2016 Sep;11(5):501-506. doi: 10.1097/COH.0000000000000301.
8
Monitoring of HIV treatment in seven countries in the WHO Region of the Americas.对世卫组织美洲区域七个国家的艾滋病毒治疗情况进行监测。
Bull World Health Organ. 2015 Aug 1;93(8):529-39. doi: 10.2471/BLT.14.147447. Epub 2015 May 27.
9
Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.加拿大不列颠哥伦比亚省针对艾滋病毒的人群层面扩大高效抗逆转录病毒治疗的成本效益:一项建模研究。
Lancet HIV. 2015 Sep;2(9):e393-400. doi: 10.1016/S2352-3018(15)00127-7. Epub 2015 Jul 16.
10
The future role of CD4 cell count for monitoring antiretroviral therapy.CD4 细胞计数在监测抗逆转录病毒治疗中的未来作用。
Lancet Infect Dis. 2015 Feb;15(2):241-7. doi: 10.1016/S1473-3099(14)70896-5. Epub 2014 Nov 19.